Location History:
- Uccle, BE (2014)
- Antwerp, BE (2015)
- Beerse, BE (2016 - 2017)
Company Filing History:
Years Active: 2014-2017
Title: Xavier Jean Michel Langlois: Pioneering Innovations in Neurological Treatments
Introduction
Xavier Jean Michel Langlois, based in Beerse, Belgium, is a distinguished inventor known for his significant contributions to the field of pharmacology. With a total of six patents to his name, Langlois has been at the forefront of developing innovative therapies aimed at treating complex neurological disorders. His latest inventions highlight his commitment to advancing medical science through creative solutions.
Latest Patents
One of Langlois's most recent patents pertains to "Piperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists." This invention addresses compounds effective in treating psychosis, including schizophrenia and schizoaffective disorder. The understanding and application of these fast-dissociating antagonists represent a significant advancement in psychotropic medication.
Another notable patent involves "combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors." This groundbreaking work focuses on combinations of inhibitors that target phosphodiesterase enzymes to enhance treatment outcomes for neurological and metabolic disorders. The implications of these inventions could revolutionize the management of various psychiatric and metabolic conditions.
Career Highlights
Langlois is a key researcher at Janssen Pharmaceutica NV, a leader in pharmaceutical innovation. His work is characterized by a seamless blend of scientific inquiry and practical application, reflecting his dedication to improving patient outcomes through innovative drug development. The environment at Janssen Pharmaceutica fosters collaboration and creativity, allowing Langlois to explore and implement his inventive ideas effectively.
Collaborations
Throughout his career, Langlois has collaborated with other esteemed professionals in the field, including Gregor James MacDonald and Marcel Frans Leopold De Bruyn. These collaborations have enabled a robust exchange of ideas and techniques, strengthening the collective effort to create groundbreaking solutions in neurology and pharmacology.
Conclusion
Xavier Jean Michel Langlois stands out as an influential inventor whose work is making significant strides in the treatment of neurological disorders. With six patents already showcasing his innovative spirit, his contributions to the pharmaceutical industry will undoubtedly continue to shape the future of medicine. As he continues his work at Janssen Pharmaceutica NV, the medical community eagerly anticipates the advancements that will emerge from his ongoing research and collaborations.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.